Dutch regulators have cleared the first human trial of an experimental gene therapy for type 2 diabetes, allowing Fractyl Health to test whether a one-time treatment could reduce reliance on drugs such as Ozempic and Wegovy.[#item_full_content]
I conflitti d’interesse di Trump, che ha investito in Meta, Bank of America e Goldman Sachs
Maggio 17, 2026
Read More [#item_full_content]
